A pooled shRNA screen for regulators of primary mammary stem and progenitor cells identifies roles for Asap1 and Prox1

BackgroundThe molecular regulators that orchestrate stem cell renewal, proliferation and differentiation along the mammary epithelial hierarchy remain poorly understood. Here we have performed a large-scale pooled RNAi screen in primary mouse mammary stem cell (MaSC)-enriched basal cells using 1295 shRNAs against genes principally involved in transcriptional regulation.MethodsMaSC-enriched basal cells transduced with lentivirus pools carrying shRNAs were maintained as non-adherent mammospheres, a system known to support stem and progenitor cells. Integrated shRNAs that altered culture kinetics were identified by next generation sequencing as relative frequency changes over time. RNA-seq-based expression profiling coupled with in vitro progenitor and in vivo transplantation assays was used to confirm a role for candidate genes in mammary stem and/or progenitor cells.ResultsUtilizing a mammosphere-based assay, the screen identified several candidate regulators. Although some genes had been previously implicated in mammary gland development, the vast majority of genes uncovered have no known function within the mammary gland. RNA-seq analysis of freshly purified primary mammary epithelial populations and short-term cultured mammospheres was used to confirm the expression of candidate regulators. Two genes, Asap1 and Prox1, respectively implicated in breast cancer metastasis and progenitor cell function in other systems, were selected for further analysis as their roles in the normal mammary gland were unknown. Both Prox1 and Asap1 were shown to act as negative regulators of progenitor activity in vitro, and Asap1 knock-down led to a marked increase in repopulating activity in vivo, implying a role in stem cell activity.ConclusionsThis study has revealed a number of novel genes that influence the activity or survival of mammary stem and/or progenitor cells. Amongst these, we demonstrate that Prox1 and Asap1 behave as negative regulators of mammary stem/progenitor function. Both of these genes have also been implicated in oncogenesis. Our findings provide proof of principle for the use of short-term cultured primary MaSC/basal cells in functional RNAi screens.

[1]  Anastasia Khvorova,et al.  Identification of genes that regulate epithelial cell migration using an siRNA screening approach , 2008, Nature Cell Biology.

[2]  J. Visvader,et al.  Mammary stem cells and the differentiation hierarchy: current status and perspectives , 2014, Genes & development.

[3]  N. Caplen,et al.  Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening , 2014, Breast Cancer Research.

[4]  G. Sauvageau,et al.  An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity. , 2010, Cell stem cell.

[5]  T. Manabe,et al.  Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities , 2005, The EMBO journal.

[6]  J. Welsh,et al.  Vitamin D(3) receptor ablation alters mammary gland morphogenesis. , 2002, Development.

[7]  Marie-Liesse Asselin-Labat,et al.  Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation , 2007, Nature Cell Biology.

[8]  G. Nossal,et al.  The Walter and Eliza Hall Institute of Medical Research , 1996, The Medical journal of Australia.

[9]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[10]  J. Visvader,et al.  Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2 , 2014, Oncogene.

[11]  A. Ashworth,et al.  Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland , 2007, The Journal of cell biology.

[12]  Wei Shi,et al.  Gata-3 Negatively Regulates the Tumor-Initiating Capacity of Mammary Luminal Progenitor Cells and Targets the Putative Tumor Suppressor Caspase-14 , 2011, Molecular and Cellular Biology.

[13]  Jane E. Visvader,et al.  In situ identification of bipotent stem cells in the mammary gland , 2014, Nature.

[14]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[15]  F. J. Livesey,et al.  Prox1 function controls progenitor cell proliferation and horizontal cell genesis in the mammalian retina , 2003, Nature Genetics.

[16]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[17]  M. Willingham,et al.  Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors , 2011, Oncogene.

[18]  Jussi Taipale,et al.  Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. , 2008, Cancer cell.

[19]  François Vaillant,et al.  Generation of a functional mammary gland from a single stem cell , 2006, Nature.

[20]  E. Fuchs,et al.  An RNA interference screen uncovers a new molecule in stem cell self-renewal and long-term regeneration , 2012, Nature.

[21]  S. Lowe,et al.  Probing tumor phenotypes using stable and regulated synthetic microRNA precursors , 2005, Nature Genetics.

[22]  Pier Paolo Di Fiore,et al.  The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells , 2009, Cell.

[23]  M. Bissell,et al.  Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1 , 1995, Molecular and cellular biology.

[24]  Wenjun Guo,et al.  Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.

[25]  Julie M Sheridan,et al.  edgeR: a versatile tool for the analysis of shRNA-seq and CRISPR-Cas9 genetic screens , 2014, F1000Research.

[26]  M. Detmar,et al.  An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype , 2002, The EMBO journal.

[27]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[28]  R. Nusse,et al.  Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. , 2010, Cell stem cell.

[29]  M. Robinson,et al.  Small-sample estimation of negative binomial dispersion, with applications to SAGE data. , 2007, Biostatistics.

[30]  N. Berns,et al.  A genome-scale in vivo RNAi analysis of epithelial development in Drosophila identifies new proliferation domains outside of the stem cell niche , 2014, Journal of Cell Science.

[31]  C. Caldas,et al.  Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland , 2012, Breast Cancer Research.

[32]  J. Hoheisel,et al.  A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype , 2013, Breast Cancer Research.

[33]  R. Nusse,et al.  Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland. , 2012, Cell stem cell.

[34]  J. Visvader,et al.  Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. , 2008, Cell stem cell.

[35]  J. Thiery,et al.  Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. , 2006, Developmental biology.

[36]  Elgene Lim,et al.  Open Access Research Article Transcriptome Analyses of Mouse and Human Mammary Cell Subpopulations Reveal Multiple Conserved Genes and Pathways , 2022 .

[37]  A. Rocha,et al.  Distinct stem cells contribute to mammary gland development and maintenance , 2011, Nature.

[38]  W. Shi,et al.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote , 2013, Nucleic acids research.

[39]  Haiyan I. Li,et al.  Purification and unique properties of mammary epithelial stem cells , 2006, Nature.

[40]  Charity W. Law,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[41]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[42]  Patrick J. Paddison,et al.  Cloning of short hairpin RNAs for gene knockdown in mammalian cells , 2004, Nature Methods.

[43]  Bogi Andersen,et al.  Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor. , 2014, Developmental cell.

[44]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[45]  Stephen J. Elledge,et al.  Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening , 2008, Science.

[46]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[47]  G. Sauvageau,et al.  A Functional Screen to Identify Novel Effectors of Hematopoietic Stem Cell Activity , 2008, Cell.

[48]  G. Dontu,et al.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells , 2004, Breast Cancer Research.

[49]  G. Kong,et al.  Constitutive overexpression of Id‐1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution , 2011, Journal of cellular physiology.

[50]  P. Kastner,et al.  MafB Restricts M-CSF-Dependent Myeloid Commitment Divisions of Hematopoietic Stem Cells , 2009, Cell.

[51]  Li Yang,et al.  Identification of multipotent mammary stem cells by protein C receptor expression , 2014, Nature.

[52]  Elaine Fuchs,et al.  Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas , 2014, Science.

[53]  Transcription factor PROX1: its role in development and cancer , 2012, Cancer and Metastasis Reviews.